论文部分内容阅读
目的探讨糖尿病治疗中应用胰岛素治疗时,一过性屈光不正的发生率及其临床特点。方法纳入糖尿病患者160例,男76例,女84例,年龄18~65岁,平均(56.26±8.13)岁。研究对象均为初次应用胰岛素的糖尿病患者,其中59例在治疗中出现一过性视物不清,后证实为屈光不正。对屈光不正的度数、出现时间、持续时间、恢复时间、血糖下降幅度、胰岛素用量进行分析。结果初次应用胰岛素的糖尿病患者,出现一过性屈光不正发生率为36.9%(59/160),出现屈光不正患者屈光度均为远视,表现为波动性屈光不正,屈光变化的程度和性质与血糖变化程度、TG及年龄有关,与胰岛素用量与HbA1c无关。结论糖尿病患者应用胰岛素治疗时,随着血糖的下降会出现远视性屈光不正。
Objective To investigate the incidence of transient refractive errors and its clinical features in the treatment of diabetes mellitus with insulin therapy. Methods A total of 160 patients with diabetes mellitus, 76 males and 84 females, aged from 18 to 65 years, with an average of (56.26 ± 8.13) years. All the subjects were diabetic patients with initial insulin therapy. Among them, 59 patients had transient visual acuity during the treatment, which was confirmed as refractive error. The degree of refractive error, the appearance of time, duration, recovery time, the decline in blood glucose, insulin dosage analysis. Results The initial incidence of diabetic patients with insulin, the incidence of transient refractive errors was 36.9% (59/160), refractive errors are hyperopia in patients with refractive errors, manifested as fluctuating refractive errors, the degree of refractive changes and The nature and degree of changes in blood glucose, TG and age, and insulin dosage has nothing to do with HbA1c. Conclusion Diabetes patients with insulin treatment, with the decline in blood glucose will appear hyperopia ametropia.